The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation.

The genetic defects underlying the pathogenesis of acute myeloid leukemia (AML) are still largely unknown. Retroviral insertion mutagenesis in mice has become a powerful tool to identify candidate genes involved in the development of leukemia and lymphoma. We have used this strategy with the 1.4 strain of Graffi murine leukemia virus (MuLV), which predominantly causes myeloid leukemias. Here, we report that Graffi-1.4-induced AML frequently harbors virus integrations in the gene encoding the transcription factor Yin Yang 1 (YY1). These integrations occurred in both orientations, and all were located in the 5' promoter region of the gene, 0.5 to 1.5 kb upstream of the major transcriptional start site. Luciferase reporter assays showed that virus integration in this region increases promoter activity and renders it independent of a functional binding site for Sp1, a major transcriptional regulator of YY1. We used the murine 32D model to study the consequence of perturbed YY1 expression for myelopoiesis. YY1 protein levels were high in 32D parental cells maintained in interleukin-3-containing medium, but they dropped when the cells were induced to differentiate by granulocyte-colony-stimulating factor (G-CSF). Strikingly, G-CSF-induced neutrophilic differentiation was reduced in 32D cell transfectants ectopically expressing YY1. In similar experiments on primary bone marrow cells, enforced YY1 expression blocked the outgrowth of CFU-GM colonies. Increased YY1 expression was seen in some cases of human AML. Collectively, these data imply a possible role of perturbed expression of YY1 in the development of AML through interference with the myeloid differentiation program in the leukemic progenitor cells.

[1]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[2]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[3]  T. Nakamura,et al.  Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. , 2001, Experimental hematology.

[4]  E. Seto,et al.  Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. , 1998, Nucleic acids research.

[5]  Bernhard Lüscher,et al.  Characterization of the Transcriptional Regulator YY1 , 1997, The Journal of Biological Chemistry.

[6]  E. Rassart,et al.  Oncogene Activation in Myeloid Leukemias by Graffi Murine Leukemia Virus Proviral Integration , 1999, Journal of Virology.

[7]  H. Yoshioka,et al.  Removal of inhibitory substances with recombinant fibronectin-CH-296 plates enhances the retroviral transduction efficiency of CD34(+)CD38(-) bone marrow cells. , 2001, Journal of biochemistry.

[8]  S. Goff,et al.  Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. , 1993, Science.

[9]  M. Asaka,et al.  Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue , 1999, Oncogene.

[10]  James R. Downing,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain , 2001, Molecular and Cellular Biology.

[11]  J. Cowland,et al.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.

[12]  Sharon Roth,et al.  The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases , 2001, Molecular and Cellular Biology.

[13]  A. Berns,et al.  Retroviral insertional mutagenesis as a strategy to identify cancer genes. , 1996, Biochimica et biophysica acta.

[14]  J. Downing,et al.  Acute myeloid leukemia. , 1999, The New England journal of medicine.

[15]  I. Touw,et al.  Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells* , 1999, The Journal of Biological Chemistry.

[16]  Ya-Li Yao,et al.  Regulation of Transcription Factor YY1 by Acetylation and Deacetylation , 2001, Molecular and Cellular Biology.

[17]  Jeng-Shin Lee,et al.  Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.

[18]  A. van der Eb,et al.  Assay of transforming activity of tumor virus DNA. , 1980, Methods in enzymology.

[19]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[20]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[21]  E. Rassart,et al.  Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent , 1993, Journal of virology.

[22]  Chi-Wai Wong,et al.  Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.

[23]  F. Dong,et al.  Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. , 1996, Blood.

[24]  J. Saffer,et al.  Developmental expression of Sp1 in the mouse , 1991, Molecular and cellular biology.

[25]  R. Perry,et al.  Characterization of the mouse gene that encodes the delta/YY1/NF-E1/UCRBP transcription factor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Löwenberg,et al.  Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. , 1998, Blood.

[27]  Yang Shi,et al.  Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality , 1999, Molecular and Cellular Biology.

[28]  D. Largaespada Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies , 2000, Leukemia.

[29]  K. Calame,et al.  YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Ya-Li Yao,et al.  The FK506‐binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1 , 2001, The EMBO journal.

[31]  Unnur Thorsteinsdottir,et al.  Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia , 2001, Molecular and Cellular Biology.

[32]  W. van Putten,et al.  Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. , 1993, The New England journal of medicine.

[33]  J. Greenberger,et al.  Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Calame,et al.  An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. , 1994, Nucleic acids research.

[35]  P. Kang,et al.  Interaction between YY1 and the Retinoblastoma Protein , 2001, The Journal of Biological Chemistry.

[36]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[37]  B. Löwenberg,et al.  Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. , 2000, Virology.

[38]  G. Nucifora The EVI1 gene in myeloid leukemia , 1997, Leukemia.

[39]  H. Scherthan,et al.  Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors? , 2000, Cancer genetics and cytogenetics.

[40]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[41]  N. Copeland,et al.  Retroviral Insertions in Evi12, a Novel Common Virus Integration Site Upstream of Tra1/Grp94, Frequently Coincide with Insertions in the Gene Encoding the Peripheral Cannabinoid Receptor Cnr2 , 1999, Journal of Virology.

[42]  M. Vidal,et al.  RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1 , 1999, The EMBO journal.

[43]  J. Shaughnessy,et al.  Leukaemia disease genes: large-scale cloning and pathway predictions , 1999, Nature Genetics.

[44]  B. Löwenberg,et al.  STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27Kip1 , 2000, Oncogene.

[45]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.